Subscribe
Contact Us
About Us
Advertise
Home
News
News from MM&M
Off the Wire
Newsletters
PMD Profiles
Agency Creative Showcase
Publication Connection
PMD Marketplace
Careers
About Us
Additional Resources
MM&M
MM&M Jobs
MAHF
Voi Consulting
Advertise
Subscribe
Get Listed
Additional Resources
RSS
|
Login
|
Register
Acquisition
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
March 09, 2010
Abbott will acquire Facet for $27 per share in cash
Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals for $52 per Share in Cash
March 02, 2010
Astellas Files Lawsuit Against OSI
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
March 01, 2010
Astellas to build a world-class oncology platform
Cephalon Exercises its Option to Acquire Ception Therapeutics
February 23, 2010
Ception Delivers Positive Results from a Phase II Study of CINQUIL in Adult Eosinophilic Asthma
Merz to Complete Acquisition of BioForm Medical
February 19, 2010
Creates a Global Leader in Medical Aesthetics
Abbott Completes Acquisition of Solvay Pharmaceuticals
February 16, 2010
Abbott Pays $6.2 Billion for Solvay Pharmaceuticals
BioMarin to Acquire LEAD Therapeutics
February 04, 2010
Key Asset is LT-673
Enzon Completes Sale of Specialty Pharmaceutical Business
January 29, 2010
Enzon received $300 million in cash
QuantRx Biomedical to Acquire NuRx Pharmaceuticals
January 29, 2010
Combination Strengthens Financial and Competitive Position
Ligand Completes Acquisition of Metabasis
January 28, 2010
Ligand gains a fully funded partnership with Roche
Ethicon Completes Acquisition of Acclarent
January 20, 2010
Opportunity to Create New Growth Platform in Surgical ENT Market
Gambro Announces Agreement to Acquire CHF Solutions, Inc.
January 20, 2010
Developer of the Aquadex FlexFlow system
Celgene Completes Acquisition of Gloucester Pharmaceuticals
January 15, 2010
Transaction completed for $340 million in cash with additional milestone opportunities of up to $300 million
Eisai Completes Acquisition of AkaRx, Inc.
January 06, 2010
Continues Development of AKR-501 for Thrombocytopenia
Anika Therapeutics Acquires Fidia Advanced Biopolymers
December 31, 2009
A Leading Innovator in Hyaluronic Acid Based Tissue Engineered Products
Ligand Completes Neurogen Acquisition
December 23, 2009
Ligand gains a fully funded partnership with Merck & Co.
Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
December 21, 2009
Chattem to lead sanofi-aventis' U.S. consumer health division
Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals
December 18, 2009
Creates Pipeline With Potential Near-Term Product Launch of Dyloject(TM)
Ethicon Announces Definitive Agreement to Acquire Acclarent
December 16, 2009
Acclarent's Broad Product Portfolio Provides New Growth Platform in ENT
Adamis Pharmaceuticals Announces Signing of Definitive Merger Agreement
December 07, 2009
Adamis to acquire La Jolla Pharmaceutical Company
Watson Completes Acquisition of Arrow Group
December 02, 2009
Watson acquired the Arrow Group for a cash payment of $1.05 billion
Enzon Announces Agreement to Sell Specialty Pharmaceutical Business
November 09, 2009
sigma-tau to acquire business for approximately $327 million in cash plus royalties
Abbott Completes Acquisition of Evalve, Inc.
November 02, 2009
Acquisition provides Abbott with a leading presence in non-surgical treatment for structural heart disease
Metabasis Announces Ligand to Acquire Metabasis for Cash and Contingent Value Rights
October 27, 2009
Ligand to Gain Fully Funded Partnership with Roche for Hepatitis and Promising Development-Stage Programs
Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
October 26, 2009
Acquisition positions Boehringer Ingelheim among the world's top animal health companies
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
October 26, 2009
Deal will Provide Cephalon New Path Forward for Development of its Tumor Necrosis Factor Inhibitor
Merck and Schering-Plough Receive Approval From European Commission for Merger
October 23, 2009
Transaction expected to close in the fourth quarter of 2009
Abbott Completes Visiogen Acquisition
October 21, 2009
Visiogen boosts Abbott's presence in the vision care segment
Dainippon Sumitomo Pharma Co., Ltd. Completes Acquisition of Sepracor Inc.
October 21, 2009
DSP acquires Sepracor for US$23.00 per share in cash
OXiGENE to Acquire VaxGen in a Stock-for-Stock Merger
October 15, 2009
Acquisition to Add Approximately $33 Million in Cash to OXiGENE's Balance Sheet
Latest News
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
Affymax® Receives $5 Million Milestone Payment on Initiation of Phase 3 Clinical Trials for Hematide in Japan
Alun Malone Joins Millennium Laboratories As New Business Development Executive
Lilly to Acquire European Rights to Pfizer Animal Health Assets
CSL Behring Receives FDA Approval of Hizentra™
EKR Therapeutics Appoints John Bailye as Interim President & Chief Executive Officer
Columbia Laboratories Enters into Purchase and Collaboration Agreement with Watson Pharmaceuticals for Progesterone Franchise
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program
Most Popular
Most Emailed
Most Recent
Adamis Pharmaceuticals Signs Agreement to Acquire Prostate Cancer Drug Candidates
Columbia Laboratories Enters into Purchase and Collaboration Agreement with Watson Pharmaceuticals for Progesterone Franchise
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
FDA Approves Exalgo Extended-Release Tablets
Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals for $52 per Share in Cash
Transdel Pharmaceuticals Appoints Terry Nida as Chief Business Officer
EKR Therapeutics Appoints John Bailye as Interim President & Chief Executive Officer
Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease
CSL Behring Receives FDA Approval of Hizentra™
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
FDA Advisory Committee Recommends Approval Of XIFAXAN® (rifaximin) Tablets, 550 Mg for Maintenance of Remission of Hepatic Encephalopathy
Affymax® Receives $5 Million Milestone Payment on Initiation of Phase 3 Clinical Trials for Hematide in Japan
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
Lilly to Acquire European Rights to Pfizer Animal Health Assets
Alun Malone Joins Millennium Laboratories As New Business Development Executive
CSL Behring Receives FDA Approval of Hizentra™
Columbia Laboratories Enters into Purchase and Collaboration Agreement with Watson Pharmaceuticals for Progesterone Franchise
EKR Therapeutics Appoints John Bailye as Interim President & Chief Executive Officer
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
Affymax® Receives $5 Million Milestone Payment on Initiation of Phase 3 Clinical Trials for Hematide in Japan
Alun Malone Joins Millennium Laboratories As New Business Development Executive
Lilly to Acquire European Rights to Pfizer Animal Health Assets
CSL Behring Receives FDA Approval of Hizentra™
EKR Therapeutics Appoints John Bailye as Interim President & Chief Executive Officer
Columbia Laboratories Enters into Purchase and Collaboration Agreement with Watson Pharmaceuticals for Progesterone Franchise
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program
Popular Topics
Acquisition
Agency
Animal Health
Biopharmaceutical
Biotech
Business
Clinical Management
Collaboration
Marketing & Communications
Medical Device
Medical Equipment
Merger
New Company
New Hire
New Hires
Personnel
Pharmaceutical
Pharmaceutical Marketplace
Pharmaceutical Products
Pipeline
Product Acquisition
Product Launch
Product Promotion
Regulatory
Research & Development